Quality Metrics for Colon & Rectal Cancers
This accreditation reflects our dedication to continuously improving the prognosis and comfort of every patient with colorectal cancer.
Commission on Cancer's Quality of Care Measures
As part of our national accreditation status, UC San Diego Health's cancer program is also accredited by the Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality.
The data presented below is included in the CoC's quality-of-care measures for colon and rectal cancer, and are for 2017, the most recent year for which data is available. (Data is provided by the National Cancer Database.)
The purpose of the data is to compare the care of colorectal cancer patients at UC San Diego Health with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all measures listed below. For more information about quality and safety measures, see Quality Care.
|Quality of Care for
Colorectal Cancer Measure
|UC San Diego Health||State of California||Pacific Region||Teaching Hospitals||All Commission on Cancer-Approved Programs|
|At least 12 regional lymph nodes removed and examined for resected colon cancer||97.7%||92.7%||93.5%||94.7%||93.2%|
|Chemo and radiation therapy, administered or recommended for resected rectal cancers||100.0%||89.2%||87.9%||84.7%||87.8%|
Hospitals Are Not All Alike
Become an Informed Consumer
At UC San Diego Health, we are dedicated to delivering the highest quality, safest care for every patient, every time. We encourage you to become an informed consumer.